Source MS Society: Ocrelizumab should be available on the NHS for everyone with primary progressive MS who could benefit. 
We call on NHS England, the National Institute of Health and Care Excellence (NICE) and Roche to work together to secure a deal to make that happen.
Raise your voice and help the MS Society tell NICE and NHS England: give people with primary progressive MS access to ocrelizumab. Sign their petition